We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity

Product News   May 21, 2018

 
New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program

Product News

LegoChem Biosciences, Inc. (LCB) has announced a worldwide license agreement with Iksuda Therapeutics for the development and commercialization of LCB73, a CD19-targeted ADC candidate for hematological tumors.

READ MORE

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Product News

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.

READ MORE

Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery

Product News

Analytik reports how the Quadram Institute has invested in a ZetaView Nanoparticle Tracking Analyser to help them develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria to generate nanoparticle sized Outer Membrane Vesicles.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE